Medical Science Liaison - Oncology

Warman O'Brien; Italia; On-site; EUR 70,000 - 90,000; Full time

Job summary

Warman O'Brien is seeking an experienced Medical Science Liaison (MSL) to join its Oncology Medical Affairs function in Italy. You will own scientific engagement across the Italian market, building relationships with KOLs and healthcare professionals while contributing to medical initiatives within a growing pharmaceutical business.

The successful candidate will work closely with Medical Affairs leadership, support RWE activities and ISSs, and ensure adherence to governance and regulatory

Qualifications

• 2–3 years MSL experience in oncology.
• Experience in solid tumours.
• PhD/PharmD/MD or equivalent.
• Proven engagement with healthcare professionals and KOLs.
• Willingness to travel across Italy.

Responsibilities

• Build and maintain relationships with KOLs and physicians across Italy.
• Communicate clinical data and medical information non-promotively.
• Gather insights on treatment practices and unmet needs.
• Support advisory boards, education programmes, and speaker development.
• Contribute to Real-World Evidence (RWE) and Investigator Sponsored Studies (ISSs).
• Develop national KOL engagement plans aligned with Medical Affairs goals.
• Collaborate with Medical Affairs, Market Access and cross-functional teams.
• Ensure activities comply with regulations and governance.

Skills

KOL engagement

Scientific communication

Data interpretation

Autonomy

Italian native

Education

MD/PhD/PharmD

Job description

Location: Italy | National Field-Based Role

Employment: Permanent

Salary: Dependent on experience

We are partnering with an established international pharmaceutical organisation seeking an experienced Medical Science Liaison (MSL) to join its growing Oncology Medical Affairs function in Italy.

This is an opportunity to take ownership of scientific engagement across the Italian market, developing relationships with leading healthcare professionals and contributing to medical initiatives within an expanding pharmaceutical business.

The successful candidate will work closely with Medical Affairs leadership and play an important role in supporting the company's oncology portfolio.

Key Responsibilities

• Build and maintain relationships with Key Opinion Leaders (KOLs), physicians, healthcare professionals and relevant medical organisations across Italy.
• Communicate clinical data, scientific evidence and medical information through non-promotional scientific exchange.
• Gather insights from healthcare professionals regarding treatment practices, emerging clinical evidence and unmet medical needs.
• Support advisory boards, medical education programmes, scientific meetings and speaker development initiatives.
• Contribute to Real-World Evidence (RWE) activities and Investigator Sponsored Studies (ISSs).
• Develop and implement national KOL engagement plans in line with Medical Affairs objectives.
• Collaborate with internal Medical Affairs, Market Access and other cross-functional stakeholders.
• Ensure all activities comply with relevant industry regulations and medical governance requirements.

Requirements

• Minimum 2-3 years of Medical Science Liaison experience, ideally within Oncology.
• Experience across oncology indications, with solid tumour experience highly desirable.
• Advanced scientific or medical qualification, such as a PhD, PharmD or MD.
• Established experience engaging healthcare professionals and KOLs.
• Strong scientific communication and clinical data interpretation skills.
• Ability to work autonomously in a nationally focused field medical position.
• Native-level Italian communication skills.
• Willingness to travel extensively across Italy.

What's on Offer?

• Join a growing international pharmaceutical organisation.
• Contribute to the development of its Oncology Medical Affairs function.
• Work closely with senior medical leadership.
• High degree of autonomy and ownership across the Italian market.
• Opportunity to support scientific engagement, medical education and evidence generation activities.